Today's fentanyl crisis: Prohibition's Iron Law, revisited

International Journal of Drug Policy

Volumn 46, Issue , 2017, Pages 156-159

  Beletsky, Leo ^a,b   Davis, Corey S ^c,d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Network for Public Health Law   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Opioids; Overdose; Pain; Policies; Prohibition; Supply reduction; Treatment access

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; FENTANYL; ILLICIT DRUG; METHADONE; NALOXONE; NARCOTIC ANALGESIC AGENT; STREET DRUG;

ALCOHOL CONSUMPTION; ARTICLE; DRUG DEPENDENCE; DRUG OVERDOSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; MENTAL HEALTH SERVICE; OPIATE ADDICTION; PAIN; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; HARM REDUCTION; HEROIN DEPENDENCE; LEGISLATION AND JURISPRUDENCE; PUBLIC POLICY; SUPPLY AND DISTRIBUTION; UNITED STATES;

ANALGESICS, OPIOID; FENTANYL; HARM REDUCTION; HEROIN; HEROIN DEPENDENCE; HUMANS; OPIOID-RELATED DISORDERS; PUBLIC POLICY; STREET DRUGS; UNITED STATES;

EID: 85025114227     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2017.05.050     Document Type: Article

References (34)

1. Alpert, A., Powell, D., Pacula, R.L., Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. National Bureau of Economic research working paper 23031. 2017 Available at http://www.nber.org/papers/w23031 (Last Accessed 17 May 2017).
2. Beletsky, L., Rich, J., Walley, A.Y., Prevention of fatal opioid overdose. The Journal of the American Medical Association 308:18 (2012), 1863–1864.
3. Beletsky, L., LaSalle, L., Newman, M., et al. Fatal re-entry: Legal and programmatic opportunities to curb opioid overdose among individuals newly released from incarceration. Northeastern University Law Journal 7 (2015), 155–215.
4. Caplehorn, J.R.M., Dalton, M.Y.N.S., Haldar, F., Petrenas, A.-M., Nisbet, J.G., Methadone maintenance and addicts’ risk of fatal heroin overdose. Substance Use & Misuse 31:2 (1996), 177–196.
5. Cicero, T.J., Ellis, M.S., Surratt, H.L., Kurtz, S.P., The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry 71:7 (2014), 821–826.
6. Cowan, R., How the narcs created crack. National Review 38 (1986), 26–31.
7. Davis, C.S., Carr, D., Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements. Drug & Alcohol Dependence 163 (2016), 100–107.
8. Davis, C.S., Carr, D.H., The law and policy of opioids for pain management, addiction, treatment, and overdose reversal. Indiana Health Law Review 14 (2017), 1–139.
9. Davis, C.S., Green, T., Beletsky, L., Action, not rhetoric, needed to reverse the opioid overdose epidemic. The Journal of Law, Medicine & Ethics 45:S1 (2017), 20–23.
10. Dowell, D., Haegerich, T.M., Chou, R., CDC guideline for prescribing opioids for chronic pain-United States. JAMA 315 (2016), 1624–1645.
11. Drug Enforcement Administration, National drug threat assessment summary, US Department of Justice (Washington, DC). 2016 Accessible at https://www.dea.gov/resource-center/2016%20NDTA%20Summary.pdf (Last Accessed 17 May 2017).
12. Gellad, W.F., Good, C.B., Shulkin, D.J., Addressing the opioid epidemic in the United States: Lessons from the Department of Veterans Affairs. JAMA Internal Medicine, 2017, 10.1001/jamainternmed.2017.0147.
13. Green, T.C., Gilbert, M., Counterfeit medications and fentanyl. JAMA Internal Medicine 176:10 (2016), 1555–1557.
14. Green, T.C., Bowman, S., Davis, C.S., Los, C., McHugh, K., Friedmann, P., Discrepancies in addressing overdose prevention through prescription monitoring programs. Drug and Alcohol Dependence 153:2 (2015), 355–358.
15. Hall, W., What are the policy lessons of National Alcohol Prohibition in the United States, 1920–1933?. Addiction 105:7 (2010), 1164–1173.
16. Jones, C.M., Christensen, A., Gladden, R.M., Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013. Drug and Alcohol Dependence 176:2 (2017), 89–95.
17. Katz, J., Drug Deaths in America Are Rising Faster Than Ever. 2017, The New York Times Accessible at https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html?_r=0 (Last accessed June 8, 2017).
18. Kertesz, S.G., Turning the tide or riptide? The changing opioid epidemic. Substance Abuse Journal 38:1 (2017), 3–8.
19. Lee, H., How dry we were: Prohibition revisited. 1963, Prentice-Hall, Englewood, N.J.
20. Levine, H.G., Reinarman, C., Alcohol prohibition and drug prohibition: Lessons from alcohol policy for drug policy. Fish, J.M., (eds.) Drugs and society: US Public Policy, 2005, Rowman & Littlefield, Lanham MD.
21. Marshall, B.D.L., Krieger, M.S., Yedinak, J., Ogera, P., Banerjee, P., Alexander-Scott, N.E., Rich, J.D., Green, T.C., Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA. IJDP, 2017, 10.1016/j.drugpo.2017.05.029.
22. Massachusetts Department of Public Health, Data Brief: Opioid- Related Overdose Deaths Among Massachusetts Residents. 2017 Accessible at http://www.mass.gov/eohhs/docs/dph/stop-addiction/current-statistics/data-brief-overdose-deaths-may-2017.pdf (Last Accessed June 8, 2017).
23. McLean, K., There's nothing here: Deindustrialization as risk environment for overdose. The International Journal on Drug Policy 29 (2016), 19–26, 10.1016/j.drugpo.2016.01.009.
24. Messac, L., Ciccarone, D., Draine, J., Bourgois, P., The good-enough science-and-politics of anthropological collaboration with evidence-based clinical research: Four ethnographic case studies. Social Science & Medicine 99:2 (2013), 176–178.
25. Miron, J.A., Zwiebel, J., Alcohol consumption during prohibition. National Bureau of Economic Research. 1991 Retrieved from http://www.nber.org/papers/w3675.
26. Park, H., Bloch, M., How the epidemic of drug overdose death ripples across America. 2016, New York Times Accessible at https://www.nytimes.com/interactive/2016/01/07/us/drug-overdose-deaths-in-the-us.html (Last Accessed 17 May 2017).
27. Patrick, S.W., Fry, C.E., Jones, T.F., Buntin, M.B., Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Affairs 35:7 (2016), 1324–1332.
28. Pew Charitable Trusts, Immigration enforcement along U.S. borders and at Ports of entry: Federal, state and local efforts. 2016 Retrieved 19 April 2017 from http://bit.ly/1yOqvH.
29. Polcyn, B., Davis, D., The legacy of Len Bias: Police treating overdoses as homicides, Fox Channel 6, October 31 2013. 2017 Accessible at http://fox6now.com/2013/10/31/the-legacy-of-len-bias-police-treating-drug-ods-as-homicides (Last Accessed 17 May 2017).
30. Rudd, R.A., Puja, S., Felicita, D., Scholl, L., Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. Morbidity and Mortality Weekly Report 65:50–51 (2016), 1445–1452.
31. Rutkow, L., Chang, H.-Y., Daubresse, M., Webster, D.W., Stuart, E.A., Alexander, G.C., Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on opioid prescribing and use. JAMA Internal Medicine 175:10 (2015), 1642–1649.
32. Schwartz, R.P., Gryczynski, J., O'Grady, K.E., Sharfstein, J.M., Warren, G., Olsen, Y., Mitchell, S.G., Jaffe, J.H., Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. American Journal of Public Health 103:5 (2013), 917–922.
33. Volkow, N.D., Frieden, T.R., Hyde, P.S., Cha, S.S., Medication-assisted therapies—Tackling the opioid-overdose epidemic. New England Journal of Medicine 370:22 (2014), 2063–2066.
34. Warburton, C., The economic results of prohibition. 1968, AMS, New York Press.